Navigation Links
Industry-First Telephone for Health Care Developed by CyraCom
Date:9/26/2007

Hospital Trials Complete for Limited-English Interpretation

TUCSON, Ariz., Sept. 26 /PRNewswire/ -- Clinically relevant timing, especially important for serving limited-English speaking patients in hospitals and health care facilities, is now markedly enhanced with the development of the industry's first dual-handset cordless phone, ClearLink(TM) Cordless.

Precedent-setting, as was CyraCom's invention of its patented dual-handset phone now known as ClearLink(TM), this new cordless phone is specifically designed for medical interpretation in health care settings. ClearLink(TM) Cordless also is patented, with an additional patent pending.

The ClearLink(TM) Cordless mobile dual-handsets provide access for language interpretation service in nearly any patient care environment. It is particularly well-suited for use in emergency, labor and delivery, physical therapy and occupational medicine departments, as well as out-patient clinics. It provides improved access to over-the-phone interpretation in areas of health care facilities with limited phone access. Another advantage of its mobility is that it enhances workflow by allowing caregivers to sequentially treat patients with a common language need while connected to the same interpreter.

ClearLink(TM) Cordless has belt clips and headsets to give caregivers more freedom of movement. Its high quality speakerphone features, including a handset volume control, enable hands-free communication. The smooth surface has a specially designed coating unique to ClearLink(TM) that helps ensure effective infection control.

"This new cordless phone can easily be set up for interpretation service when clinicians need it, and virtually anywhere," said CyraCom CEO Michael Greenbaum. CyraCom introduced its first patented dual-handset phone in 1995.

Leading hospitals nationwide have trialed ClearLink(TM) Cordless as part of CyraCom's ongoing program of bringing innovative products and services to its clients.

"By providing high quality sound and mobility, the ClearLink(TM) Cordless handsets and headset option make over-the-phone interpretation much more effective while treating patients during physical therapy treatment," said Nancy L. Gessner, Chief Physical Therapist, South Nassau Communities Hospital.

CyraCom's now serves more than 1,000 hospitals and health care facilities nationwide. Its language services include on-demand telephonic interpretation, document translation and medical interpreter testing and training. Its technology won a national health care award from InfoWorld magazine. The company has been named to both the Inc. 500 and Inc. 5000 lists of fastest-growing private companies in the United States.

For more information about ClearLink(TM) Cordless, call 800-713-4950 or visit http://www.cyracom/news


'/>"/>
SOURCE CyraCom
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. The ABCs of telephone regulation in Wisconsin
2. Bio-Plex Cytokine Immunoassays and ELISA: Comparison of Two Methodologies in Testing Samples From Asthmatic and Healthy Children, Rev A
3. Web-based reporting credited with states top healthcare ranking
4. Visions, Part II: Preizler sees IT leading incremental health system change
5. Visions: Preizler offers insurers perspective on healthcare IT
6. Federal bill would set healthcare IT standards
7. IRS ruling could speed healthcare technology adoption
8. Bill would provide federal aid for healthcare IT
9. Cardinal Health likes growth potential of Viasys NeuroCare Group
10. DHC 2007: Controlling health IT costs the key to capturing value
11. Siemens health services president calls IT benefits unassailable
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... 2017 Aratana Therapeutics, Inc. (NASDAQ: ... licensing, development and commercialization of innovative biopharmaceutical products for ... in North America 2016. ... based on the FDA approval of three innovative therapeutics ... (capromorelin oral solution) and NOCITA ® (bupivacaine ...
(Date:1/20/2017)... -- http://www.Financialbuzz.com - According to ... of death worldwide. There were 8.2 million cancer related ... deaths increased gradually over time, the death rates have ... cancers continues to drive demand of biological therapies for ... Insights, Inc. cancer biological therapy market size was USD 61.3 ...
(Date:1/19/2017)... 19, 2017 /PRNewswire -- WuXi AppTec, a leading ... and technology platform, today announced that it has ... preclinical drug discovery contract research organization (CRO). After ... wholly-owned subsidiary of WuXi, and will continue to ... greater services. The acquisition will further strengthen WuXi,s ...
(Date:1/19/2017)... 19, 2017  ArmaGen, Inc., today announced that ... as chief executive officer, as well as a ... to ArmaGen more than 17 years of executive ... of biotherapeutics and pharmaceuticals. "Mathias ... experience and skillset necessary to lead ArmaGen to ...
Breaking Biology Technology:
(Date:1/4/2017)... 2017  CES 2017 – Valencell , the ... announced the launch of two new versions of ... biometric sensor modules that incorporate the best of ... expertise. The two new designs include Benchmark BE2.0, ... and Benchmark BW2.0, a 2-LED version of its ...
(Date:12/20/2016)... RALEIGH, N.C. and GENEVA, Dec, 20, 2016 ... performance biometric data sensor technology, and STMicroelectronics ... across the spectrum of electronics applications, announced today ... scalable development kit for biometric wearables that includes ... integrated with Valencell,s Benchmark™ biometric sensor ...
(Date:12/15/2016)... VANCOUVER, Canada and BADEN-BADEN, Germany ... Solutions, a leading global financial services provider, today announced an ... in passive behavioural biometrics, to join forces. The partnership will ... fraud mitigation strategies in compliance with local data protection regulation. ... In ...
Breaking Biology News(10 mins):